hobbyleft.blogg.se - Prolia copay card program

Prolia copay card program full#

See for full Terms and Conditions.Ĭontraindications: Prolia ® is contraindicated in patients with Ongoing activation of the Prolia ® Co-pay Card is contingent on the submission of the required Explanation of Benefits (EOB) form by the healthcare provider’s office within 180 days of the use of the Prolia Co-pay Card.Patients are responsible for all amounts that exceed this limit. Prolia ® patients pay as little as $25 for each dose, and Amgen will pay the remaining eligible out-of-pocket costs on behalf of the patient until the Amgen payments have reached either the Maximum Program Benefit or the Patient Total Program Benefit.Please ask your Prolia Support Representative to help you understand eligibility for the Prolia Co-pay Card, whether your insurance coverage is likely to result in you reaching the Maximum Program Benefit or your Patient Total Program Benefit amount by calling 1-84. Whether you are eligible to receive the Maximum Program Benefit or Patient Total Program Benefit is determined by the type of plan coverage you have. If a patient’s commercial insurance plan imposes different or additional requirements on patients who receive Prolia Co-pay Card benefits, Amgen has the right to reduce or eliminate those benefits. The Prolia Co-pay Card provides support up to the Maximum Program Benefit or Patient Total Program Benefit. The Prolia Co-pay Card does not cover any other costs related to office visits or administration of Prolia. Out-of-pocket costs include co-payment, co-insurance, and deductible out-of-pocket costs.

The Prolia ® Co-pay Card may help lower your Prolia out-of-pocket medication costs.

It is not valid for cash paying patients or where prohibited by law. The program is not valid for patients whose Prolia prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state healthcare program.

The Prolia ® Co-pay Card is open to patients with commercial insurance, regardless of financial need.

The following summary is not a substitute for reviewing the Terms and Conditions in their entirety. SUMMARY OF TERMS AND CONDITIONSIt is important that every patient read and understand the full Prolia ® Co-pay Card Terms and Conditions. Prolia ® is indicated as a treatment to increase bone mass in women at high riskįor fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. Patients Prolia ® also reduced the incidence of vertebral fractures. Prolia ® is indicated as a treatment to increase bone mass in men at high risk forįracture receiving androgen deprivation therapy for nonmetastatic prostate cancer. High risk of fracture is defined asĪ history of osteoporotic fracture, multiple risk factors for fracture, or patients who haveįailed or are intolerant to other available osteoporosis therapy. Systemic glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone andĮxpected to remain on glucocorticoids for at least 6 months.

In men and women at high risk of fracture who are either initiating or continuing

Prolia ® is indicated for the treatment of glucocorticoid-induced osteoporosis Or multiple risk factors for fracture or patients who have failed or are intolerant to other Osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, Prolia ® is indicated for treatment to increase bone mass in men with Postmenopausal women with osteoporosis, Prolia ® reduces the incidence of Indicated for the treatment of postmenopausal women with osteoporosis at high risk forįracture, defined as a history of osteoporotic fracture, or multiple risk factors forįracture or patients who have failed or are intolerant to other available osteoporosis therapy.